1003-3734
2010 Issue 9
..............page:729-730
Inhibitory effects of 10 flavonoid glycosides on the pathways of diabetic pathogenesis
cheng li-yan; shi hong(zhejiang academy of medical sciences; hangzhou 310013; china)
cheng li-yan; shi hong(zhejiang academy of medical sciences; hangzhou 310013; china)
..............page:793-796
Anti-inflammatory and antipyretic effect of new Houttuynia Cordata injection and the mechanism
zhang mei-yu; li yi-kui; yan wei-juan; lin cheng-ren; jin long; zhang jin-yan; he ping; sun wei-wei; hao wei; li lian-da(r&d center; xiyuan hospital; china academy of chinese medial sciences; beijing 100091; china)
zhang mei-yu; li yi-kui; yan wei-juan; lin cheng-ren; jin long; zhang jin-yan; he ping; sun wei-wei; hao wei; li lian-da(r&d center; xiyuan hospital; china academy of chinese medial sciences; beijing 100091; china)
..............page:775-779
..............page:728
Anaphylactic reactions of new Houttuynia Cordata injection
zhang mei-yu; li lian-da; li yi-kui; zhang jia; hao wei(r&d center; xiyuan hospital; china academy of chinese medial sciences; beijing 100091; china)
zhang mei-yu; li lian-da; li yi-kui; zhang jia; hao wei(r&d center; xiyuan hospital; china academy of chinese medial sciences; beijing 100091; china)
..............page:780-784,796
FITC-labeled thymopentin:synthesis,purification and characteristics
zheng ai-ping1; 2; wang jian-cheng1; zhang xuan1; zhang qiang1(1 department of pharmaceutics; peking university school of pharmaceutical sciences; beijing 100083; china; 2 department of pharmaceutics; institute of pharmacology and toxicology of the academy of military medical sciences; beijing 100850; china)
zheng ai-ping1; 2; wang jian-cheng1; zhang xuan1; zhang qiang1(1 department of pharmaceutics; peking university school of pharmaceutical sciences; beijing 100083; china; 2 department of pharmaceutics; institute of pharmacology and toxicology of the academy of military medical sciences; beijing 100850; china)
..............page:813-816
Considerations of the discount rate in pharmacoeconomic evaluation in China
sun li-hua; zong xin(school of business administration; shenyang pharmaceutical university; shenyang 110016; china)
sun li-hua; zong xin(school of business administration; shenyang pharmaceutical university; shenyang 110016; china)
..............page:737-739
Establishment of hPPARγ2-overexpressing cell model and the relationship with tumor malignancy
li yan; xin hong-qi; zuo ming-xin; chen xiao-guang(institute of materia medica; chinese academy of medical sciences & peking union medical college; beijing 100050; china)
li yan; xin hong-qi; zuo ming-xin; chen xiao-guang(institute of materia medica; chinese academy of medical sciences & peking union medical college; beijing 100050; china)
..............page:785-792
Comparison of the efficacy and safety of thrombolytic therapy using low dose reteplase and alteplase in patients over 75 years with acute myocardial infarction
zhang shuang-yue; wang xue-qing; liu chang-tao; bian qiu-wu; meng xiao-jing; liu xiao-yuan(department of cardiology; first hospital of qinhuangdao; qinhuangdao 066200; china)
zhang shuang-yue; wang xue-qing; liu chang-tao; bian qiu-wu; meng xiao-jing; liu xiao-yuan(department of cardiology; first hospital of qinhuangdao; qinhuangdao 066200; china)
..............page:766-768
Effects of flavones from Zea Mays L(ZMLF) on blood lipid and hemorheologic parameters in hyperlipemic rats
jing yi1; 2; jing rong-qin3; ren yuan2; hu tian-hui2(1 huaiyin institute of technology; huaian 223003; china; 2 gansu college of traditional chinese medicine; lanzhou 730000; china; 3 department of pharmacy; baiyin second people s hospital; baiyin 730900; china)
jing yi1; 2; jing rong-qin3; ren yuan2; hu tian-hui2(1 huaiyin institute of technology; huaian 223003; china; 2 gansu college of traditional chinese medicine; lanzhou 730000; china; 3 department of pharmacy; baiyin second people s hospital; baiyin 730900; china)
..............page:797-800
Synthesis and pharmacological activity of aminothiazoles
yuan jing1; huang chang-jiang1; zhang shi-jun1; sheng xiao-rong2; he su-bing2(1 tianjin institute of pharmaceutical research; tianjin 300193; china; 2 anhui institute of medical sciences; hefei 230061; china)
yuan jing1; huang chang-jiang1; zhang shi-jun1; sheng xiao-rong2; he su-bing2(1 tianjin institute of pharmaceutical research; tianjin 300193; china; 2 anhui institute of medical sciences; hefei 230061; china)
..............page:801-804
Research progress in disposition of flavonoids in vivo
zeng xiao-li1; xie yan1; 2; yuan xiu-rong1; 2(1 shanghai university of traditional chinese medicine; shanghai 201203; china; 2 shanghai zhong yi da yuan chuang technology co.; ltd.; shanghai 201203; china)
zeng xiao-li1; xie yan1; 2; yuan xiu-rong1; 2(1 shanghai university of traditional chinese medicine; shanghai 201203; china; 2 shanghai zhong yi da yuan chuang technology co.; ltd.; shanghai 201203; china)
..............page:750-754
..............page:726
Research progress in rhubarb polysaccharides
xie yan; li guo-wen; ma yue-ming(shanghai university of traditional chinese medicine; shanghai 201203; china)
xie yan; li guo-wen; ma yue-ming(shanghai university of traditional chinese medicine; shanghai 201203; china)
..............page:755-758
Rationality of combination and proportion of cefotaxime/sulbactam in vitro
li chang-qing; chen wei; wang ting(xiangbei welman pharmaceutical co.; ltd.; changsha 410000; china)
li chang-qing; chen wei; wang ting(xiangbei welman pharmaceutical co.; ltd.; changsha 410000; china)
..............page:759-761
A novel intranasal corticosteroid:fluticasone furoate
wang shen-qing; ni chao; liu hong-yan(department of otorhinolaryngology; the first affiliated hospital of medical school of zhejiang university; hangzhou 310003; china)
wang shen-qing; ni chao; liu hong-yan(department of otorhinolaryngology; the first affiliated hospital of medical school of zhejiang university; hangzhou 310003; china)
..............page:731-736
Determination of fluconazole concentration in human serum by RP-HPLC and its clinical application
sheng xiao-yan1; xiong xin1; yang wen-ling2; duan jing-li1(1 department of pharmacy; 2 department of nephrology; peking university third hospital; beijing 100191; china)
sheng xiao-yan1; xiong xin1; yang wen-ling2; duan jing-li1(1 department of pharmacy; 2 department of nephrology; peking university third hospital; beijing 100191; china)
..............page:772-774,804
..............page:727
Efficacy of silibinin capsules in treating 50 patients with nonalcoholic fat liver
sun yan-hui(department of digestive; the northern branch of xinjiang people s hospital; urumqi 830000; china)
sun yan-hui(department of digestive; the northern branch of xinjiang people s hospital; urumqi 830000; china)
..............page:769-771
Related issues in phase 0 clinical trials in research and development of investigational new drugs
yang zhi-min; sun tao; zhao de-heng(center for drug evaluation; state food and drug administration; beijing 100038; china)
yang zhi-min; sun tao; zhao de-heng(center for drug evaluation; state food and drug administration; beijing 100038; china)
..............page:743-745
Pharmacokinetics of geniposide through 4 routes of administration
yang ming1; 2; chen xiao-yan1; zhang hai-yan1; wang jian-min3; lu qian1; song wei1(1 ministry of education key laboratory of modern traditional chinese medicine; jiangxi traditional chinese medicine; nanchang 330004; china; 2 chengdu university of traditional chinese medicine; chengdu 611137; china; 3 jiangxi medical college of basic medical; nanchang 330004; china)
yang ming1; 2; chen xiao-yan1; zhang hai-yan1; wang jian-min3; lu qian1; song wei1(1 ministry of education key laboratory of modern traditional chinese medicine; jiangxi traditional chinese medicine; nanchang 330004; china; 2 chengdu university of traditional chinese medicine; chengdu 611137; china; 3 jiangxi medical college of basic medical; nanchang 330004; china)
..............page:746-749,754
Genetic polymorphism of GNB3 C825T in association with efficacy of metoptolol
han lu-lu; li na; jiang xiong-jing; liu yu-qing; liu hong; li yi-shi(key laboratory of clinical trial research in cardiovascular drugs ministry of health; cardiovascular institute and fuwai hospital; peking union medical college and chinese academy of medical science; beijing 100037; china)
han lu-lu; li na; jiang xiong-jing; liu yu-qing; liu hong; li yi-shi(key laboratory of clinical trial research in cardiovascular drugs ministry of health; cardiovascular institute and fuwai hospital; peking union medical college and chinese academy of medical science; beijing 100037; china)
..............page:762-765,768
..............page:725
To establish adverse drug reactions damage compensation system in China
yang yue1; jiang zhi-gang1; 2; li ye1(1 school of business administration; shenyang pharmaceutical university; shenyang 110016; china; 2 liaoning zhongshen medicinal new production co.; ltd.; shenyang 110002; china)
yang yue1; jiang zhi-gang1; 2; li ye1(1 school of business administration; shenyang pharmaceutical university; shenyang 110016; china; 2 liaoning zhongshen medicinal new production co.; ltd.; shenyang 110002; china)
..............page:740-742,745
Pharmacokinetics and relative bioavailability of indapamide controlled release tablets in Beagle dogs
liu xiao-juan1; 2; nie shu-fang1; pan wei-san1; sun yu-qi2; liu wen-tao1(1 school of pharmacy; shenyang pharmaceutical university; shenyang 110016; china; 2 school of pharmacy; liaoning medical university; jinzhou 121001; china)
liu xiao-juan1; 2; nie shu-fang1; pan wei-san1; sun yu-qi2; liu wen-tao1(1 school of pharmacy; shenyang pharmaceutical university; shenyang 110016; china; 2 school of pharmacy; liaoning medical university; jinzhou 121001; china)
..............page:808-812
Effect of matrine on angiotensin Ⅱ-induced proliferation and collagen synthesis in human fetal lung fibroblast cells
dai you-ping1; li qi-yi1; kong jun-hong2; zhu xuan-xuan3; yan shi-hai3(1 jiangsu province hospital of traditional chinese medicine; nanjing 210029; china; 2 nanjing university of traditional chinese medicine; nanjing 210029; china; 3 clinical research institute pharmacology room; jiangsu province hospital of traditional chinese medicine; nanjing 210029; china)
dai you-ping1; li qi-yi1; kong jun-hong2; zhu xuan-xuan3; yan shi-hai3(1 jiangsu province hospital of traditional chinese medicine; nanjing 210029; china; 2 nanjing university of traditional chinese medicine; nanjing 210029; china; 3 clinical research institute pharmacology room; jiangsu province hospital of traditional chinese medicine; nanjing 210029; china)
..............page:805-807,812